文献
J-GLOBAL ID:202102256149073387
整理番号:21A1886049
疾患修飾抗リウマチ薬の配列:トシリズマブ単独療法の経路と予測因子【JST・京大機械翻訳】
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
著者 (9件):
Solomon Daniel H.
(Division of Rheumatology, Brigham and Women’s Hospital, Boston, USA)
,
Solomon Daniel H.
(Division of Pharmacoepidemiology, Brigham and Women’s Hospital, Boston, USA)
,
Xu Chang
(Division of Rheumatology, Brigham and Women’s Hospital, Boston, USA)
,
Collins Jamie
(Department of Orthopaedic Surgery, Brigham and Women’s Hospital, Boston, USA)
,
Kim Seoyoung C.
(Division of Rheumatology, Brigham and Women’s Hospital, Boston, USA)
,
Kim Seoyoung C.
(Division of Pharmacoepidemiology, Brigham and Women’s Hospital, Boston, USA)
,
Losina Elena
(Department of Orthopaedic Surgery, Brigham and Women’s Hospital, Boston, USA)
,
Yau Vincent
(Brigham and Women’s Hospital, Genentech, San Francisco, California, USA)
,
Johansson Fredrik D.
(Chalmers University of Technology, Gothenburg, Sweden)
資料名:
Arthritis Research & Therapy (Web)
(Arthritis Research & Therapy (Web))
巻:
23
号:
1
ページ:
1-9
発行年:
2021年
JST資料番号:
U7412A
ISSN:
1478-6362
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)